Experimental investigations into the irregular synthesis of iron(iii) terephthalate metal-organic frameworks MOF-235 and MIL-101

MOF-235(Fe) and MIL-101(Fe) are two well-studied metal-organic frameworks (MOFs) with dissimilar crystal structures and topologies. Previously reported syntheses of the former show that it has greatly varying surface areas, indicating a lack of phase purity of the products, i.e. the possible presence of both MOFs in the same sample. To find the reason for this, we have tested and modified the commonly used synthesis protocol of MOF-235(Fe), where a 3 : 5 molar ratio of iron(iii) ions and a terephthalic acid linker is heated in a 1 : 1 DMF : ethanol solvent at 80 degrees C for 24 h. Using XRD and BET surface area (SA(BET)) measurements, we found that it is difficult to obtain a pure phase of MOF-235, as MIL-101 also appears to form during the solvothermal treatment. Comparison of the XRD peak height ratios of the synthesis products revealed a direct correlation between the MOF-235/MIL-101 content and surface area; more MOF-235 yields a lower surface area and vice versa. In general, using a larger (3 : 1) DMF : ethanol ratio than that reported in the literature and a stoichiometric (4 : 3) Fe(iii) : TPA ratio yields a nearly pure MOF-235 product (SA(BET) = 295 m(2) g(-1), 67% yield). An optimized synthesis procedure was developed to obtain high-surface area MIL-101(Fe) (SA(BET) > 2400 m(2) g(-1)) in a large yield and at a previously unreported temperature (80 degrees C vs. previously used 110-150 degrees C). In situ X-ray scattering was utilized to investigate the crystallization of MOF-235 and MIL-101. At 80 degrees C, only MOF-235 formed and at 85 and 90 degrees C, only MIL-101 formed

Comprehensive 4D velocity mapping of the heart and great vessels by cardiovascular magnetic resonance

<p>Abstract</p> <p>Background</p> <p>Phase contrast cardiovascular magnetic resonance (CMR) is able to measure all three directional components of the velocities of blood flow relative to the three spatial dimensions and the time course of the heart cycle. In this article, methods used for the acquisition, visualization, and quantification of such datasets are reviewed and illustrated.</p> <p>Methods</p> <p>Currently, the acquisition of 3D cine (4D) phase contrast velocity data, synchronized relative to both cardiac and respiratory movements takes about ten minutes or more, even when using parallel imaging and optimized pulse sequence design. The large resulting datasets need appropriate post processing for the visualization of multidirectional flow, for example as vector fields, pathlines or streamlines, or for retrospective volumetric quantification.</p> <p>Applications</p> <p>Multidirectional velocity acquisitions have provided 3D visualization of large scale flow features of the healthy heart and great vessels, and have shown altered patterns of flow in abnormal chambers and vessels. Clinically relevant examples include retrograde streams in atheromatous descending aortas as potential thrombo-embolic pathways in patients with cryptogenic stroke and marked variations of flow visualized in common aortic pathologies. Compared to standard clinical tools, 4D velocity mapping offers the potential for retrospective quantification of flow and other hemodynamic parameters.</p> <p>Conclusions</p> <p>Multidirectional, 3D cine velocity acquisitions are contributing to the understanding of normal and pathologically altered blood flow features. Although more rapid and user-friendly strategies for acquisition and analysis may be needed before 4D velocity acquisitions come to be adopted in routine clinical CMR, their capacity to measure multidirectional flows throughout a study volume has contributed novel insights into cardiovascular fluid dynamics in health and disease.</p